Milbemycin oxime/lufenuron: Difference between revisions
Appearance
Content deleted Content added
Anypodetos (talk | contribs) added Category:Combination drugs using HotCat |
m Moving Category:Novartis brands to Category:Drugs developed by Novartis per Wikipedia:Categories for discussion/Log/2023 December 9#Category:AstraZeneca brands |
||
(24 intermediate revisions by 19 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Combination drug}} |
|||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = 408380655 |
|||
⚫ | |||
⚫ | |||
<!--Combo data--> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Clinical data--> |
|||
⚫ | |||
| |
| tradename = |
||
| Drugs.com = {{drugs.com|pro|sentinel_flavor_tabs}} |
|||
⚫ | |||
| |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
||
⚫ | |||
| pregnancy_category |
| pregnancy_category = |
||
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
|||
| |
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
||
| |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
||
| |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|||
| legal_status |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = |
||
<!--Identifiers--> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
| DrugBank = |
|||
<!--Chemical data--> |
|||
}} |
}} |
||
'''Sentinel Flavor Tabs''', |
The combination '''milbemycin oxime/lufenuron''' (trade names '''Sentinel Flavor Tabs''', by [[Novartis|Novartis Animal Health]], and '''Program plus''') is a [[parasite]] control drug in which the [[active ingredient]], [[milbemycin oxime]], eliminates worms, while a second active ingredient, [[lufenuron]], arrests the development of eggs and [[larva]]e, preventing them from maturing and continuing the infestation of an animal. This combination is registered for animal use only. To achieve efficacy, the treatment is administered once monthly, together with food, in a dosage suitable for the weight of the affected animal. The usual ratio is 500 μg milbemycin oxime and 10 mg lufenuron/kg body weight. Novartis indicates the proper dosage by color-coding the packages.<ref>[http://www.sentinel.novartis.us Novartis Animal Health - Sentinel Flavor Tabs],</ref> |
||
Several 2002 studies by Novartis demonstrate that |
Several 2002 studies by Novartis demonstrate that milbemycin oxime/lufenuron compares favorably to some other treatments, such as the [[moxidectin]] injection. The combination is considered effective in the elimination of fleas, and the prevention of infection from [[hookworm]] (''Ancylostoma caninum''), [[heartworm]] (''Dirofilaria immitis''), [[roundworm]]s, [[whipworm]]s (''Trichuris vulpis''), and ascarids (''[[Toxocara canis]]'' and ''[[Toxascaris leonina]]'').{{Citation needed|date=April 2009}} The USA FDA approval for Sentinel says "Concurrent use of insecticides may be necessary".<ref>[http://www.accessdata.fda.gov/scripts/animaldrugsatfda/details.cfm?dn=140-084 NADA number 140-084]</ref> It is the concurrent use of Sentinel and [[nitenpyram]] (Capstar) that has an FDA-approved indication "to kill adult fleas".<ref>[http://www.accessdata.fda.gov/scripts/animaldrugsatfda/details.cfm?dn=140-204 NADA number 140-204]</ref> |
||
==Side effects== |
|||
However, Sentinel Tabs can lead to a [[Adverse effect (medicine)|negative physical response]] in some animals, most dangerously those that test positively for heartworm disease before receiving the treatment. Less serious side effects are an upset stomach or loss of appetite, various skin irritations, and mood changes. |
|||
Milbemycin oxime/lufenuron can lead to a [[Adverse effect (medicine)|negative physical response]] in some animals, most severely those that have heartworm disease or weigh under 2 lbs. It is recommended that all dogs be tested for heartworm prior to taking the medication to minimize this risk. Serious side effects may include lethargy, weakness, stumbling, seizures, coma, excessive drooling, and wide dilated pupils. Less serious side effects are an upset stomach or loss of appetite, various skin irritations, and mood changes. <ref>{{Cite web| vauthors = Gollakner R |title=Milbemycin Oxime|url=https://vcacanada.com/know-your-pet/milbemycin-oxime| work = VCA Canada Hospitals }}</ref> |
|||
==References== |
==References== |
||
{{Reflist}} |
{{Reflist}} |
||
{{DEFAULTSORT:Milbemycin oxime lufenuron}} |
|||
[[Category:Antiparasitic agents]] |
[[Category:Antiparasitic agents]] |
||
[[Category:Veterinary drugs]] |
[[Category:Veterinary drugs]] |
||
[[Category: |
[[Category:Drugs developed by Novartis]] |
||
[[Category:Combination |
[[Category:Combination antibiotics]] |
||
{{Veterinary-med-stub}} |
{{Veterinary-med-stub}} |